HanesBrands of New York City announced on July 24 it paid about $575 million for Maidenform in Iselin. Both are clothing distributors.
Quest Sells Drug Royalty Rights
Diagnostic information provider Quest Diagnostics in Madison announced on July 18 the $485 million sale of its rights to royalties from experimental cancer drug ibrutinib to Royalty Pharma of New York City, an acquirer of biopharmaceutical royalty interests.